DAUNORUBICIN BROMOKETAL
UNII 3Z1AE1LY2D

Substance Identification & Data

This profile provides standardized clinical and technical data for Daunorubicin Bromoketal, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3Z1AE1LY2D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 106401-68-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
3Z1AE1LY2D
CAS Registry Number
106401-68-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DAUNORUBICIN BROMOKETAL
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C29H34BrNO11
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
JIMPRCTWUQVCIT-BJRCHLRVSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
72941581
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c12c(C(=O)c3c(C1=O)cccc3OC)c(O)c4c(c2O)C[C@](C[C@@]4(O[C@@H]5O[C@@H](C)[C@H]([C@H](C5)N)O)[H])(C(OC)(CBr)OC)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Daunorubicin Bromoketal. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

DAUNORUBICIN BROMO DIMETHYL KETAL
DAUNORUBICIN BROMOKETAL
VALRUBICIN IMPURITY, DAUNORUBICIN BROMOKETAL [USP IMPURITY]

Systematic Nomenclature

(8S,10S)-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-8-(2-BROMO-1,1-DIMETHOXYETHYL)-6,8,11-TRIHYDROXY-1-METHOXY-7,8,9,10-TETRAHYDROTETRACENE-5,12-DIONE
5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-8-(2-BROMO-1,1-DIMETHOXYETHYL)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, (8S,10S)-

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound